动脉瘤性蛛网膜下腔出血后Takotsubo心肌病的预测因素及主动脉内球囊反搏患者的结局
该研究回顾性分析1096例aSAH患者,其中26例发生Takotsubo心肌病(TC)。多因素分析显示女性、Hunt-Hess分级>III级、动脉瘤>7mm及临床血管痉挛是TC的独立危险因素;TC患者即使置入IABP,不良结局和死亡率仍显著高于非TC患者,但积极动脉内血管内治疗可能改善部分血管痉挛患者的结局。
要点
- 女性、Hunt-Hess>III级、动脉瘤>7mm、临床血管痉挛是aSAH后TC的危险因素。
- TC患者预后差,即使使用IABP,mRS>2和死亡率仍显著高于非TC患者。
- 对部分血管痉挛的TC患者,积极动脉内血管内治疗可能改善结局。
核心结论
- aSAH后TC多见于女性、大动脉瘤、临床分级差及临床血管痉挛的患者,这些患者神经功能预后差且死亡率高,即使置入IABP亦不能消除风险。
- 对选择性血管痉挛患者,积极动脉内血管内治疗可能改善TC患者的结局。
研究设计与样本
- 根据改良Mayo Clinic标准判定TC,末次随访时以mRS>2定义不良结局。
主要发现
- 26例aSAH患者发生TC。
- 多因素logistic回归显示女性(OR 8.2,p=0.005)、Hunt-Hess分级>III级(OR 7.6,p<0.001)、动脉瘤大小>7mm(OR 3,p=0.011)及临床血管痉挛(OR 2.9,p=0.037)是TC的危险因素。
- TC患者即使置入IABP,末次随访不良结局(mRS>2)比例为77% vs 47%(p=0.004),死亡率为27% vs 11%(p=0.018),均高于非TC患者。
- 在TC患者中,积极动脉内血管内治疗血管痉挛与良好结局相关(末次随访mRS≤2比例100% vs 53%,p=0.040)。
关键数值与推荐
- TC诊断依据改良Mayo Clinic标准。
- 不良结局定义为末次随访mRS>2。
- TC危险因素包括女性(OR 8.2)、Hunt-Hess>III级(OR 7.6)、动脉瘤>7mm(OR 3)、临床血管痉挛(OR 2.9)。
临床怎么用
- 对aSAH女性、Hunt-Hess>III级、动脉瘤>7mm或伴临床血管痉挛的患者,应警惕TC发生并加强心脏监测。
- TC患者即使使用IABP,仍需密切随访神经功能结局。
- 对合并血管痉挛的TC患者,可考虑积极动脉内血管内治疗以改善预后。
局限性
- 回顾性研究设计,部分数据来自前瞻性数据库但整体为回顾性分析。
- TC患者样本量较小(26例),统计效能有限。
- 单中心研究,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Takotsubo cardiomyopathy (TC) in patients with aneurysmal subarachnoid hemorrhage (aSAH) is associated with high morbidity and mortality. Previous studies have shown that female patients presenting with a poor clinical grade are at the greatest risk for developing TC. Intra-aortic balloon pumps (IABPs) are known to support cardiac function in severe cases of TC, and they may aid in the treatment of vasospasm in these patients. In this study, the authors investigated risk factors for developing TC in the setting of aSAH and outcomes among patients requiring IABPs. METHODS: The authors retrospectively reviewed the records of 1096 patients who had presented to their institution with aSAH. Four hundred five of these patients were originally enrolled in the Barrow Ruptured Aneurysm Trial, and an additional 691 patients from a subsequent prospectively maintained aSAH database were analyzed. Medical records were reviewed for the presence of TC according to the modified Mayo Clinic criteria. Outcomes were determined at the last follow-up, with a poor outcome defined as a modified Rankin Scale (mRS) score > 2. RESULTS: TC was identified in 26 patients with aSAH. Stepwise multivariate logistic regression analysis identified female sex (OR 8.2, p = 0.005), Hunt and Hess grade > III (OR 7.6, p < 0.001), aneurysm size > 7 mm (OR 3, p = 0.011), and clinical vasospasm (OR 2.9, p = 0.037) as risk factors for developing TC in the setting of aSAH. TC patients, even with IABP placement, had higher rates of poor outcomes (77% vs 47% with an mRS score > 2, p = 0.004) and mortality at the last follow-up (27% vs 11%, p = 0.018) than the non-TC patients. However, aggressive intra-arterial endovascular treatment for vasospasm was associated with good outcomes in the TC patients versus nonaggressive treatment (100% with mRS ≤ 2 at last follow-up vs 53% with mRS > 2, p = 0.040). CONCLUSIONS: TC after aSAH tends to occur in female patients with large aneurysms, poor clinical grades, and clinical vasospasm. These patients have significantly higher rates of poor neurological outcomes, even with the placement of an IABP. However, aggressive intra-arterial endovascular therapy in select patients with vasospasm may improve outcome.
引用
- Catapano JS, Ducruet AF, Frisoli FA, et al. Predictors of the development of takotsubo cardiomyopathy in aneurysmal subarachnoid hemorrhage and outcomes in patients with intra-aortic balloon pumps. J Neurosurg. 2020. PMID: 32886915. doi:10.3171/2020.5.JNS20536
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。